asco.org2 天
Outcomes of tyrosine kinase inhibitors (TKI) after immunotherapy in unresectable or ...
This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...
asco.org2 天
Treatment of hepatocellular carcinoma with tyrosine kinase inhibitors: Real-world outcomes ...
This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...
asco.org10 天
Conflict of Interest (COI)
The American Society of Clinical Oncology (ASCO) is a professional oncology society committed to conquering cancer through research, education, prevention, and the delivery of high-quality patient ...
asco.org3 天
An armored GPC3-directed CAR-T for refractory or relapsed hepatocellular carcinoma in China ...
This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...
asco.org3 天
A phase I trial using CD19 CAR-T expressing PD-1/CD28 chimeric switch-receptor for ...
This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...
asco.org3 天
Biomarker testing patterns in patients with stage IV non-small cell lung cancer (NSCLC) in ...
This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...
asco.org3 天
A phase I study of GPC3 targeted CAR-T cell therapy in advanced GPC3-expressing ...
This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...
asco.org3 天
Safety and early efficacy results from a phase 1, multicenter trial of PSMA-targeted ...
This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...
asco.org3 天
Phase 1 study of P-PSMA-101 CAR-T cells in patients with metastatic castration-resistant ...
This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...
asco.org13 天
ASCO Overview
Conquering cancer through research, education, and promotion of the highest quality patient care. ASCO is supported by its affiliate organization, Conquer Cancer, the ASCO Foundation, which funds ...
asco.org4 天
About ASCO
Founded in 1964, the American Society of Clinical Oncology is the world's leading professional organization for physicians and oncology professionals caring for people with cancer.
asco.org3 天
Nivolumab and ipilimumab in advanced non small cell lung cancer previously treated with PD1 ...
This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...